Compare Moderna, Inc. (MRNA) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Rocket Lab USA Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Rocket Lab USA Inc trades at $73.13 (market cap $41.08B). The key difference: Rocket Lab USA Inc is the larger of the two by market cap, and Moderna, Inc. is trading nearer its 52-week high, Rocket Lab USA Inc nearer its low. Which is the better fit depends on your goals.
| MRNA | RKLB | |
|---|---|---|
Market Cap | $23.60B | $41.08B |
Sector | Health | Technology |
52-Week High | $81.80 | $150.23 |
52-Week Low | $22.36 | $39.48 |
Enterprise Value | $19.70B | $39.83B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
